IRIS
CRISCUOLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.967
EU - Europa 1.830
AS - Asia 1.381
SA - Sud America 375
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 43
OC - Oceania 3
Totale 5.782
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.847
RU - Federazione Russa 905
CN - Cina 471
SG - Singapore 416
IT - Italia 387
BR - Brasile 305
SE - Svezia 204
VN - Vietnam 181
HK - Hong Kong 146
DE - Germania 89
CA - Canada 64
FR - Francia 61
GB - Regno Unito 43
IN - India 39
FI - Finlandia 37
BD - Bangladesh 32
MX - Messico 25
PL - Polonia 25
AR - Argentina 23
EC - Ecuador 22
NL - Olanda 21
ZA - Sudafrica 19
JP - Giappone 17
ES - Italia 15
TR - Turchia 13
AT - Austria 10
IE - Irlanda 10
IQ - Iraq 9
CO - Colombia 8
CR - Costa Rica 8
ID - Indonesia 8
LT - Lituania 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
UA - Ucraina 6
UZ - Uzbekistan 6
CL - Cile 5
JO - Giordania 5
MA - Marocco 5
PH - Filippine 5
SV - El Salvador 5
JM - Giamaica 4
PK - Pakistan 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AU - Australia 3
CM - Camerun 3
EG - Egitto 3
HN - Honduras 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
A1 - Anonimo 2
BE - Belgio 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
KR - Corea 2
NP - Nepal 2
RS - Serbia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
VE - Venezuela 1
Totale 5.603
Salva come PNG Salva come JPEG
Città #
Ashburn 283
Dallas 282
Singapore 215
Moscow 202
San Jose 159
Milan 150
Hong Kong 144
Beijing 101
Shanghai 88
Ho Chi Minh City 77
New York 63
Council Bluffs 56
Hefei 52
Los Angeles 47
Lauterbourg 42
Phoenix 39
Princeton 39
Lawrence 38
Santa Clara 36
São Paulo 35
Rome 29
Hanoi 28
Helsinki 26
Munich 26
Brescia 24
Warsaw 20
Atlanta 18
Montreal 18
Denver 16
Orem 16
Stockholm 16
Falkenstein 15
Nuremberg 15
Chennai 14
Johannesburg 14
Tokyo 14
Toronto 14
Naples 13
Haiphong 12
Brooklyn 11
Cesano Boscone 11
The Dalles 11
Boston 10
Dublin 10
Frankfurt am Main 10
Amsterdam 9
Bologna 9
Houston 9
London 9
Miano 9
Poplar 9
Turin 9
Belo Horizonte 8
Chicago 8
Guangzhou 8
Mexico City 8
Porto Alegre 8
Rio de Janeiro 7
The Bronx 7
Vienna 7
Guayaquil 6
Lappeenranta 6
San José 6
Seattle 6
Washington 6
Boardman 5
Columbus 5
Florence 5
Manaus 5
Quito 5
Salvador 5
San Francisco 5
Shenzhen 5
Tashkent 5
Tianjin 5
Amman 4
Ancona 4
Ankara 4
Barnet 4
Campinas 4
Caxias do Sul 4
Charlotte 4
Curitiba 4
Da Nang 4
Florianópolis 4
Hangzhou 4
Hải Dương 4
Kuala Lumpur 4
Las Vegas 4
Lecce 4
Manchester 4
Miami 4
Milwaukee 4
New Delhi 4
Pittsburgh 4
Pune 4
Riyadh 4
Sorocaba 4
South San Francisco 4
Turku 4
Totale 2.863
Salva come PNG Salva come JPEG
Nome #
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 245
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 208
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 185
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 157
The interferon landscape along the respiratory tract impacts the severity of COVID-19 153
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 148
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 142
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 141
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 139
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 139
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 139
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 136
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 135
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 121
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 119
The initial interplay between HIV and mucosal innate immunity 118
Bacteriophages and Their Immunological Applications against Infectious Threats 117
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 116
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 114
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 111
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 109
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 108
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 106
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 106
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 103
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 101
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 100
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 97
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 95
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 95
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 94
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 93
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 92
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 90
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 90
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 90
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 89
Role and potential therapeutic use of antibodies against herpetic infections 89
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 89
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 87
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 86
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 85
Viral Respiratory Pathogens and Lung Injury 84
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 84
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 83
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 78
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 76
Tracking remyelination in a model of multiple sclerosis: Visual evoked potentials reveal therapeutic effect from brain stimulation and exercise 71
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 66
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 57
Next Generation Vaccines for Infectious Diseases 54
Phage Therapy: An Alternative to Antibiotics 52
An Exploratory Survey on the Use of Anal Cytology as a Tool for Anal Cancer Screening in Italy 36
Long-Term Stability Bio-Reconfigurable Differential Impedance Electronic Platform for Virus Diagnostic 24
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccination 21
miR-29a and miR-15b Modulate SARS-CoV-2 Beta and Omicron Infection in Human Lung Epithelial Cells 13
Multi-sensor electronic platform for high resolution HIV antigen detection 5
null 1
Totale 5.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202265 0 0 0 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024315 1 20 42 62 19 62 9 25 13 8 18 36
2024/2025892 81 20 13 35 33 94 158 170 90 63 58 77
2025/20263.259 233 279 373 423 305 96 259 229 779 136 69 78
2026/2027808 191 164 184 269 0 0 0 0 0 0 0 0
Totale 5.782